share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:擬議出售證券
美股sec公告 ·  05/02 15:30
Moomoo AI 已提取核心訊息
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 9,555 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market value of $83,489, were acquired on 05/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 4,782 shares by the officer in the past three months, which had gross proceeds of $53,181.
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 9,555 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market value of $83,489, were acquired on 05/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 4,782 shares by the officer in the past three months, which had gross proceeds of $53,181.
根據最新文件,Arcutis Biotherapeutics, Inc.高管伯內特·帕特里克定於2024年2月5日出售9,555股普通股。這些股票的總市值爲83,489美元,於2024年1月5日通過Arcutis Biotherapeutics的限制性股票背心收購。該交易是在該高管在過去三個月中出售了4,782股股票之後進行的,總收益爲53,181美元。
根據最新文件,Arcutis Biotherapeutics, Inc.高管伯內特·帕特里克定於2024年2月5日出售9,555股普通股。這些股票的總市值爲83,489美元,於2024年1月5日通過Arcutis Biotherapeutics的限制性股票背心收購。該交易是在該高管在過去三個月中出售了4,782股股票之後進行的,總收益爲53,181美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息